Skip Navigation

Preoperative high dose rate brachytherapy for rectal cancer

Guidance issued Guidance issued
 
IP Guidance Number: IPG201
 
Summary:
 The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on preoperative high dose rate brachytherapy for rectal cancer.
Description:
 Rectal cancer is a common form of bowel cancer. Preoperative high dose rate brachytherapy involves placing radioactive material in or close to the tumour to shrink it before surgery.
Arrangements:

Other (see guidance)
Topic Area:

Cancer
Digestive system
Specialty:

Clinical oncology
Gastro-enterology
Medical oncology
Specialist advice has
been sought from:

Royal College of Radiologists

Association of Coloproctology of Great Britain and Ireland

Date notified to NICE: 12 August 2005
Provisional Consultation Date: Summer 2006
Guidance Publication Date: 13 December 2006
Contact Details:
Project Manager
(for general enquiries or comments)		 Ben Doak
Technical Lead
(for procedure specific enquiries or comments) 		Helen Gallo
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
Links:

Search NICE guidance


Advanced guidance search

Related information

See NICE guidance in practice

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance